CBIT Top Stories
A novel nanoparticle-based treatment that combines two innovative tumor-targeting techniques has the potential to improve therapeutic outcomes for people with glioblastoma, suggests research published in Science Advances.
- March 30, 2022
Using bioadhesive nanoparticles from the laboratory of Dr. W. Mark Saltzman, Dr. Michael Girardi and his team collaborated with Dr. Saltzman and loaded them with a one-two punch of chemotherapy plus immunotherapy to study its impact in skin cancer. The results may have significant impact for how skin cancer tumors are treated.
- September 16, 2021
Spring Health Notches A $190 Million Series C At A $2 Billion Valuation, Making CEO April Koh The Youngest Woman To Run A UnicornSource: Forbes
During her undergraduate years at Yale University, April Koh learned firsthand how frustrating and expensive it can be to find effective help for mental health illnesses. Her best friend and roommate cycled through multiple doctors and medications for an eating disorder, and ultimately needed a leave of absence to secure treatment; Koh, meanwhile, was dealing with her own mental health issues and struggling to find the right course of treatment.
- July 21, 2021Source: TechCrunch
Research says that counterfeit medication is the cause of 1 million deaths per year. One-tenth of this number comes from Africa. Counterfeiting is hard to detect, investigate, quantify or stop. It is a global problem, with annual earnings from substandard drugs standing at over $100 billion.
- May 26, 2021Source: PR Newswire
Visionairy Health (VH), a Health-tech AI company, announced today that it has obtained CE Marking for X1, its artificial intelligence (AI) based chest x-ray triage and prioritization product. X1 is a state-of-the-art medical device that uses deep learning to analyze chest x-rays, flagging those images that are suggestive of the presence of one or more of 15 pre-specified findings (including tuberculosis, pneumothorax, and lung nodules). It has been trained using hundreds of thousands of chest x-rays from dozens of geographical locations. X1 is PACS agnostic and can be easily integrated with existing radiology software. The software's notifications act as a secondary check in parallel to physicians' independent assessment to ensure that imaging studies with any prespecified findings are brought to their immediate attention.
- March 23, 2021
With their aim of increasing diversity in the medical field, the Diversifi team tackles structural racism in healthcare from multiple angles: the initiative helps make these careers more accessible to underrepresented groups, as well as supports the growth of a workforce that is more capable of providing unbiased healthcare to these populations.
- March 04, 2021Source: Yale Daily News
Members of the New Haven community may soon have a new way to get their prescriptions. Pills2Me — an early-stage company founded by Leslie Asanga MPH ’20 — offers people the opportunity to have their prescriptions delivered from local pharmacies to their doorstep. The platform can currently be accessed through the company’s website and as an app. A toll-free number is also available for placing orders and is primarily geared toward elderly members of the community who may not want to download the app. The service can pick up and deliver prescriptions from any pharmacy to those who need it. The company is headquartered in Las Vegas, Nevada, but is relaunching in New Haven with a goal to start delivering prescriptions this April.
- February 17, 2021
Leslie Asanga (PharmD, MBA, MPH), a pharmacist and recent graduate of the Yale School of Public Health, developed Pills2Me as a solution for vulnerable populations who cannot pick up their prescriptions during the COVID-19 pandemic.
- February 01, 2021
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
- December 14, 2020
Yale Lifesciences Pitchfest 2020, presented by the Blavatnik Fund for Innovation at Yale, took place on Thursday, December 3rd and Friday, December 4th.